N-Nitrosamines risk mitigation via Active packaging
Products
Information
The N-Sorb Nitrosamine Mitigation Solution leverages company's proven 3-Phase Activ-Polymer(TM) platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals. This technology can be deployed in multiple formats by integrating active material science into polymers. For example, the technology can be incorporated into a blister format that integrates a piece of N-Sorb Activ-Film(TM) material into each individual Activ-Blister(TM) cavity. This same platform is currently trusted by global brands to protect sensitive Active Pharmaceutical Ingredients (APIs) from degradation due to moisture and oxygen exposure. Alternatively, the technology can be seamlessly integrated into a container closure system. N-Sorb's intelligent design allows it to react with nitrosamine precursors in the packaging headspace to inhibit nitrosamine formation and scavenge nitrosamine impurities post-formation. Aptar's N-Sorb nitrosamine mitigation solution has been accepted into the U.S. Food & Drug Administration's (FDA) Emerging Technology Program (ETP), which helps promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.
